跳至主要内容
临床试验/NL-OMON31537
NL-OMON31537已完成不适用

The Ehlers-Danlos syndrome and regional anesthesia - The Ehlers-Danlos syndrome and regional anesthesia

niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • For EDS patients
  • - People with all types of the Ehlers-Danlos Syndrome except type IV (the vascular type), proven by a geneticist or a comparably qualified person
  • - 18 to 65 years old
  • - Infomed consent;For the control group
  • - All subjects are matched with a patient from the EDS group for age and sex

排除标准

  • For EDS patients
  • - EDS type IV (vascular type)
  • - No informed consent
  • - Younger than 18 or older than 65 years old
  • - Co-existing disease which increases the risk for regional anesthesia, this according to prudent daily clinical practice in the OR
  • - Hereditary or acquired (including drug induced) bleeding disorders
  • - Periferal mononeuropathy, polyneuropathy, Multiple Sclerosis or other relevant neurologic disorders;Control group
  • - EDS or direct family with EDS because of the possibility of undiagnosed EDS in the subject
  • - No informed consent
  • - Younger than 18 or older than 65 years old
  • - Co-existing disease which increases the risk for regional anesthesia, this according to prudent daily clinical practice in the OR
  • - Hereditary or acquired (including drug induced) bleeding disorders
  • - Periferal mononeuropathy, polyneuropathy, Multiple Sclerosis or other relevant neurologic disorders

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验